Noticias de ABUS_US

Noticias del mercado

Últimas noticias sobre ABUS_US — 42 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ABUS_US ✕ 42 resultados
24/04/2026 ABUS_US — MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving Average - Here's What Happened
23/04/2026 ABUS_US — Yahoo Finance
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran
23/04/2026 ABUS_US — Xã Thanh Hà ES ← EN
ABUS Arbutus Biopharma Corporation supera las estimaciones de ganancias del cuarto trimestre de 2025, las acciones suben casi un tres por ciento gracias al aumento de los ingresos año tras año. - Señales de comercio social

ABUS Arbutus Biopharma Corporation supera las estimaciones de ganancias del cuarto trimestre de 2025, las acciones suben casi un tres por ciento gracias al aumento de los ingresos año tras…

22/04/2026 ABUS_US — haiphong.gov.vn
ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates, shares rise nearly three percent on soaring year over year revenue. - Annual Summary
22/04/2026 ABUS_US — sonla.gov.vn
ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates, shares rise nearly three percent on soaring year over year revenue. - Annual Summary
20/04/2026 ABUS_US — tayninh.gov.vn
Arbutus (ABUS) Stock: Stability Assessment (Momentum Fading) 2026-04-20 - Real-time Trade Ideas
20/04/2026 ABUS_US — MyChesCo
Arbutus Drug Candidate Receives FDA Fast Track Designation
18/04/2026 ABUS_US — vinhcong.tayninh.gov.vn
Arbutus (ABUS) Stock Upside Volume (+0.85%) 2026-04-18 - Community Sell Signals
18/04/2026 ABUS_US — ADVFN
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
17/04/2026 ABUS_US — DirectorsTalk Interviews
Arbutus Biopharma (ABUS) Stock Analysis: Unveiling an 11.5% Upside in the Biotech Sector
17/04/2026 ABUS_US — Sahm
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
17/04/2026 ABUS_US — Yahoo Finance
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
15/04/2026 ABUS_US — European AIDS Treatment Group
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
15/04/2026 ABUS_US — TipRanks
Arbutus Biopharma Gains FDA Fast Track for Imdusiran
15/04/2026 ABUS_US — MarketScreener
Arbutus Biopharma Says Imdusiran Receives FDA Fast Track Designation for Chronic Hepatitis B
15/04/2026 ABUS_US — Stock Titan
[8-K] Arbutus Biopharma Corp Reports Material Event
15/04/2026 ABUS_US — Yahoo Finance ES ← EN
Arbutus recibe la designación de vía rápida de la FDA de EE. UU. para Imdusiran para el tratamiento de la hepatitis B crónica
15/04/2026 ABUS_US — GlobeNewswire
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
15/04/2026 ABUS_US — Seeking Alpha
Arbutus wins FDA fast track tag for lead asset (ABUS:NASDAQ)
15/04/2026 ABUS_US — Minichart
Arbutus Biopharma Corporation Files Form 8-K with SEC – Company Details, Address, and NASDAQ Listing Information 24252675

Página 1 de 3

keyboard_arrow_up